A panel of healthcare industry leaders warned Thursday that President Donald Trump’s most favored nations drug pricing policy risks choking off future medical innovation, even as they praised his broader vision of putting patients in control of their healthcare dollars.
Read Full Article: https://dailycaller.com/2026/02/20/daily-caller-live-jenn-pellegrino-charlie-sauer-seth-lederman-brent-yessin/
